Skip to Content

Painless Drug Injections

HP Labs has used its inkjet technology to make a micro-needle drug patch.
September 11, 2007

Researchers at Hewlett Packard Labs (HP Labs) have engineered a drug patch that painlessly delivers medications through the skin via tiny micro-needles. The technology is modeled after HP’s inkjet-printer technology.

Ouchless: A close-up of the prototype skin patch designed by researchers at HP Labs reveals the intricate components involved in this drug-delivery system. Micro-needles (the sparkling dots on the top of the black square platform) dispense medicine from tiny reservoirs. A microprocessor (gold square) is programmed to control dosage timing, size, and history.

A single patch outfitted with hundreds of micro-needles could potentially deliver multiple drugs at preprogrammed intervals, without the pain and hassle of conventional needles. The company has announced a licensing deal with Crospon, a medical-device developer based in Galway, Ireland, that will manufacture and market the “smart” patch.

“There are a few patches out there for drugs like nicotine and fentanyl, very small and potent molecules that go across the skin on their own,” says Samir Mitragotri, a researcher at the University of California, Santa Barbara (UCSB), who specializes in new drug-delivery devices. “They don’t need any help. For these molecules, you can buy a patch and it can last up to a week. The problem comes when you try to deliver drugs that are large in size, or water-soluble. And those are the kinds of molecules for which we need to break the skin barrier.”

A single micro-needle measures a couple hundred micrometers, a length that could penetrate the outer layer of skin, delivering a drug directly to the underlying capillary bed without triggering nerve endings located deeper in the skin.

Over the past few years, researchers have explored several methods of using such micro-needles for drug delivery; strategies ranged from coating the micro-needles with drugs to pumping tiny amounts through micro-needles in controlled doses. Scientists at HP Labs realized that this latter approach resembled the inner workings of an inkjet printer–hundreds of tiny nozzles, spraying small amounts of ink at specific times and in preprogrammed patterns.

Janice Nickel, principal scientist at HP Labs, worked to reengineer the inkjet technology as a drug-delivery system, using HP’s thermal inkjet printer, or bubble jet, as a model. The bubble jet gets its name from its ink-pumping mechanism: each ink reservoir contains a tiny resistor that heats the area, creating a bubble that displaces the ink, pushing a small amount through the nozzle and onto the paper. Nickel and her colleagues designed the drug-dispensing patch in a similar manner, using heat to pump a fluid through tiny, 150-micrometer-long needles.

The prototype patch, which is about one inch square, contains 400 cylindrical reservoirs, each less than one cubic millimeter. Each reservoir is connected to a micro-needle, and the whole array is fueled by a low-power battery and controlled by an embedded microchip that’s programmed to heat up any given reservoir to deliver a specific drug. The design challenge, according to Nickel, was in localizing the thermal energy to a specific reservoir. “You have 400 reservoirs close together, and you want to activate one reservoir without activating any reservoirs around it, so you don’t get any cross talk.”

Crospon, the company that licensed the technology, has expressed interest in using the patch to painlessly deliver insulin. It’s also exploring the possibility of delivering multiple drugs through a single patch, over a long period of time. The array is also scalable, and it can be designed to contain tens or even hundreds of reservoirs, depending on its intended therapeutic use.

Nickel adds that down the line, the patch may be customized to the patient. For example, tiny sensors embedded in a patch could detect when medication is needed and treat an asthma attack in the middle of the night. Or a patch could automatically deliver insulin when it detects that glucose levels are low.

“I even had ideas in terms of military applications,” says Nickel. “You could put sensors on the device to detect chemical or biological weapons, and develop the appropriate antidote for the pathogen dependent on what was detected by the sensors. So there are a myriad of applications for this technology.”

Mitragotri of UCSB says that, with such advances in transdermal drug-delivery systems, the hypodermic needle may one day be no more than a painful memory. “A decade down the road, I envision more drugs to be delivered through patches,” he says. “For the patient, it means that instead of hypodermic needles, they could slap on a patch that could be delivered over a long period of time, in a painless way, and they can control delivery.”

Keep Reading

Most Popular

wet market selling fish
wet market selling fish

This scientist now believes covid started in Wuhan’s wet market. Here’s why.

How a veteran virologist found fresh evidence to back up the theory that covid jumped from animals to humans in a notorious Chinese market—rather than emerged from a lab leak.

light and shadow on floor
light and shadow on floor

How Facebook and Google fund global misinformation

The tech giants are paying millions of dollars to the operators of clickbait pages, bankrolling the deterioration of information ecosystems around the world.

masked travellers at Heathrow airport
masked travellers at Heathrow airport

We still don’t know enough about the omicron variant to panic

The variant has caused alarm and immediate border shutdowns—but we still don't know how it will respond to vaccines.

egasus' fortune after macron hack
egasus' fortune after macron hack

NSO was about to sell hacking tools to France. Now it’s in crisis.

French officials were close to buying controversial surveillance tool Pegasus from NSO earlier this year. Now the US has sanctioned the Israeli company, and insiders say it’s on the ropes.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.